Related by context. All words. (Click for frequent words.) 70 pharmacodynamic properties 69 CG# [003] 69 fosbretabulin 68 pharmacodynamic PD 68 dose proportionality 68 preclinically 67 somatostatin analog 67 favorable pharmacokinetic profile 67 VAPRISOL 67 oral prodrug 67 edifoligide 67 MP4OX 66 relapsed MM 66 platelet inhibitor 66 Subgroup analysis 66 SYN# 66 lenalidomide dexamethasone 66 paricalcitol 66 receptor antagonism 66 Pharmacokinetics PK 66 ENMD # 66 TG# [003] 66 intracoronary 66 liposomal formulation 66 riociguat 66 AKT inhibitor 66 Preclinical studies 66 analgesic efficacy 66 pharmacokinetic parameters 66 pharmacodynamic effects 66 ritonavir boosted 66 cardioprotective effects 66 PRT# 66 Pemetrexed 66 selective modulator 66 solithromycin 66 vidofludimus 66 Annexin V 66 p# inhibitor 66 Aclidinium 66 indibulin 66 S/GSK# 65 plasma pharmacokinetics 65 HuMax EGFr 65 factor Xa inhibitor 65 DAPT 65 plasma kallikrein inhibitor 65 pharmacokinetic interactions 65 rhITF 65 pain palliation 65 ALB # 65 erythropoietic 65 PDE4 inhibitor 65 vitro experiments 65 antiangiogenic therapy 65 neuroprotectant 65 Hsp# Inhibitor 65 clevidipine 65 PROCHYMAL 65 MAGE A3 ASCI 65 genotypic resistance 65 APTIVUS r 65 systemically administered 65 intranasal formulation 65 antitumor effect 65 bortezomib Velcade 65 pharmacokinetics PK 65 clinically meaningful reductions 65 BAL# [002] 65 selective inhibition 65 oral rivaroxaban 65 Aurora Kinase 65 radiolabeled TM# 65 preclinical efficacy 65 potent antiproliferative 65 QT QTc 65 imexon 65 dosage regimens 65 CIMZIA ™ 65 MGd 64 selective agonist 64 GAMMAGARD 64 immune modulating 64 DCCR 64 IGF 1R inhibitor 64 florbetaben 64 histone deacetylase inhibitor 64 Kahalalide F 64 CCR2 64 Xanafide 64 orally bioavailable 64 radiolabeled 64 anti fibrotic 64 maximally tolerated dose 64 pegylated liposomal doxorubicin 64 cytoprotective 64 Teriflunomide 64 antiresorptive 64 GFT# 64 Anticalins ® 64 pharmacokinetic equivalence 64 inecalcitol 64 antiproliferative effects 64 PEGPH# 64 antifibrotic 64 ZOLINZA 64 Panzem R NCD 64 thalidomide Thalomid 64 neuroprotective properties 64 abacavir lamivudine 64 trodusquemine 64 Interferon alpha 64 Pertuzumab 64 zonisamide SR 64 achieved statistical significance 64 sorafenib tablets 64 levodopa induced dyskinesia 64 nelfinavir 64 coadministration 64 DFMO 64 CCR5 inhibitor 64 JAK inhibitor 64 Carvedilol 64 immunomodulatory properties 64 antidiabetic 64 Tarceva TM 64 metaglidasen 64 mGluR2 NAM 64 pharmacokinetic characteristics 64 concurrent chemoradiation 64 pharmacokinetic PK study 64 anticancer activity 64 gamma secretase inhibitor 64 Degarelix 64 clomipramine 64 hyperinsulinemic euglycemic clamp 63 hepatic fibrosis 63 thorough QT 63 hematological parameters 63 LB# [003] 63 microdose 63 salmeterol fluticasone 63 cardioprotection 63 mTOR inhibition 63 viral kinetics 63 Aplidin 63 highly selective inhibitor 63 Kinoid 63 resolvin 63 BoNTA 63 Capesaris 63 nucleoside analog 63 clinically meaningful efficacy 63 CBLC# 63 vinca alkaloid 63 pathophysiological effects 63 weekly subcutaneous injections 63 pharmacokinetic PK profile 63 DU #b 63 orally dosed 63 Hedgehog inhibitor 63 dose dependently 63 Traficet EN 63 Amplimexon 63 paclitaxel poliglumex 63 tipranavir 63 flavopiridol 63 Lixivaptan 63 mouse xenograft models 63 selective agonists 63 CYT# potent vascular disrupting 63 gemcitabine cisplatin 63 sorafenib Nexavar 63 ALA PDT 63 antiproliferative 63 ATACAND 63 hyperalgesia 63 CTAP# Capsules 63 Archexin 63 statistically significant efficacy 63 Virulizin ® 63 gemcitabine Gemzar ® 63 K ras mutations 63 tumorigenicity 63 mediated inhibition 63 pan HDAC inhibitor 63 antiplatelet agent 63 cannabinor 63 pharmacodynamic profile 63 NOD SCID mice 63 murine model 63 Phase 1a clinical 63 adenosine injection 63 teriflunomide 63 Trofex 63 bendamustine 63 busulfan 63 Darusentan 63 metastatic neuroendocrine tumors 63 GMX# 63 antiarrhythmic 63 intravenously administered 63 irbesartan 63 aspirin clopidogrel 63 anti leukemic 63 cardiac repolarization 63 galiximab 63 mecamylamine 63 AST ALT 63 receptor inhibitor 63 GRN# 63 OHR/AVR# 63 M1 muscarinic 63 neuroprotective effects 63 PEGylated interferon 63 administered subcutaneously 63 ADAGIO study 63 potentiation 63 BRAF inhibitor 63 Adenoscan 63 Eligen R B# 63 Randomized trials 63 apremilast 63 DEB# 63 Aflibercept 63 MTP inhibitor 63 Zemplar Capsules 63 alagebrium 63 Aggrastat ® tirofiban hydrochloride 63 Spiegelmer ® 63 pharmacologic intervention 63 gemtuzumab ozogamicin 63 NF kB Decoy 63 β blockers 63 Enzastaurin 63 interleukin IL -# 63 tarenflurbil 63 Tasigna prolongs 63 ARIKACE ™ 63 PPAR gamma agonist 63 rFVIIa 63 VA# [002] 63 RLY# 63 bardoxolone methyl 63 recurrent glioblastoma multiforme 63 HCV replication 63 LT NS# 63 bronchodilatory 63 targeted radiotherapeutic 63 rHuEPO 63 trastuzumab Herceptin ® 62 Pimavanserin 62 CA4P 62 melphalan prednisone 62 Enkephalin 62 #mg dose [001] 62 rosuvastatin #mg 62 muscarinic 62 neratinib 62 liposomal doxorubicin 62 AMD# [003] 62 effector function 62 CGRP 62 RAPAFLO R 62 immunomodulatory therapy 62 bezafibrate 62 nadolol 62 ATL# [002] 62 MVA MUC1 IL2 62 Factor VIIa 62 neurologic progression 62 depsipeptide 62 receptor blocker 62 Seliciclib 62 favorable tolerability 62 Squalamine 62 tumor necrosis 62 bupropion SR 62 ANAVEX #-# [001] 62 alicaforsen enema 62 alpha 2a 62 TRO# 62 ZACTIMA 62 epithelial sodium 62 novel VDA molecule 62 CLORETAZINE TM VNP#M 62 peripherally acting 62 factor Xa 62 sargramostim 62 direct thrombin inhibitors 62 Protelos 62 NMDA antagonist 62 vivo potency 62 antiangiogenic agent 62 SSc 62 farletuzumab 62 Tyrima 62 OMP #M# 62 pharmacodynamics PD 62 insulin sensitizing 62 receptor tyrosine kinase inhibitor 62 Anti VEGF 62 YONDELIS 62 PEGylated anti 62 Amphinex ® 62 beta 1a 62 GHRH 62 systemic bioavailability 62 mTOR inhibitors 62 olmesartan 62 BNC# 62 CDK inhibitor 62 idraparinux 62 topically administered 62 redox active 62 partial agonists 62 intravesical 62 DXL# 62 Multimeric 62 NMIBC 62 VELCADE melphalan 62 intraperitoneal 62 biochemical abnormalities 62 alvespimycin 62 vascular disrupting agents 62 ZD# [001] 62 cytostatic 62 Azedra 62 basal bolus regimen 62 pharmacodynamic markers 62 demonstrated antitumor activity 62 NF kappaB activation 62 bronchodilation 62 Mipomersen 62 Vascugel ® 62 ESBA# 62 intraventricular 62 pharmacologically active isomer 62 xenograft models 62 Safinamide 62 hereditary deficiency 62 subcutaneously administered 62 GLYX 62 bile acid sequestrant 62 selective adenosine 62 HYLENEX recombinant 62 Trandolapril 62 Ceplene/IL-2 62 CCX# 62 DNA methylation markers 62 vasoactive 62 P2Y 62 CIMZIA TM 62 THR beta agonist 62 Fulvestrant 62 SERCA2a 62 aplindore 62 endothelin antagonists 62 small molecule activators 62 radiation sensitizer 62 cortical stimulation 62 bovine thrombin 62 LEXIVA r 62 SCH # 62 HMG CoA reductase inhibitors 62 HCV protease inhibitors 62 Ophena TM 62 chemokine receptor 62 unresectable tumors 62 Phase Ib study 62 tipranavir r 62 GW# [003] 62 tecarfarin 62 Orally administered 62 Onconase 62 intratumoral injection 62 N acetylcysteine 62 cMET 62 RhuDex R 62 tumor regressions 62 chemosensitivity 62 Inhaled AAT 62 TAKSTA 62 lenalidomide Revlimid 62 Temsirolimus 62 EDEMA3 trial 62 polymerase inhibitor 62 Pharmacokinetic 62 transdermally 62 noninferiority 62 PSMA ADC 62 intradermal injection 62 atrasentan 62 Immunohistochemical analysis 62 intravenous dosing 62 scintigraphic 62 chemopreventive agent 62 somatostatin analogue 62 prucalopride 62 Lucentis ranibizumab Genentech 62 IAP inhibitor 62 atazanavir ritonavir 62 immunofluorescence staining 62 alkylating agent 62 SGS# 62 Fenretinide 62 CCR5 antagonist 62 oral FTY# 62 PTHrP 62 nanopharmaceutical 62 antiandrogens 62 peptide conjugated 62 CA9 SCAN 62 MabCampath 62 tranilast 62 calcitonin gene related 62 BENICAR HCT 62 Blinatumomab 62 MICARDIS ® 62 JAK2 inhibitor 62 bolus injection 62 systemic hypotension 62 prostate carcinoma 62 TLK# 62 pharmacokinetic pharmacodynamic 62 lesional 62 taxane resistant 62 HIF PH inhibitors 62 Elvitegravir 62 liposomal amphotericin B 62 nicardipine 62 pharmacodynamic endpoints 62 BENICAR 62 selective antagonist 62 NP2 62 Omacetaxine mepesuccinate 61 intraperitoneally 61 osteogenic 61 HER2 overexpression 61 RE LY trial 61 Kaplan Meier analysis 61 potent antitumor activity 61 Lisofylline 61 Vidaza azacitidine 61 TLR agonists 61 Inosine 61 NATRECOR ® 61 ibandronate 61 abacavir Ziagen 61 pramlintide metreleptin combination 61 Cimzia TM 61 novel oral anticoagulant 61 Dasatinib 61 FUSILEV enhances 61 GRNCM1 61 potent inhibition 61 caspofungin 61 antitumor activity 61 plasma renin activity 61 uricase 61 anti neoplastic 61 Symadex 61 PEG IFN 61 corticosteroid dexamethasone 61 antifolates 61 Non inferiority 61 Aliskiren 61 Aptivus ® 61 Vidofludimus 61 neuroregenerative 61 BEZ# 61 Angiotensin converting enzyme 61 wilate ® 61 rHuPH# 61 multicenter Phase II 61 EOquin TM 61 urate lowering 61 preclinical pharmacokinetic 61 JAK inhibitors 61 BrachySil TM 61 HCV replicon 61 NS5B polymerase 61 Pitavastatin 61 MET amplification 61 Zoraxel 61 cardiac toxicity 61 syngeneic 61 gemcitabine Gemzar 61 octreotide 61 daily subcutaneous injections 61 potent anticancer 61 Glypromate 61 prostanoid 61 acetonide FA 61 thrombin receptor 61 posaconazole 61 immunoconjugate 61 retaspimycin 61 immunomodulatory effects 61 IFN beta 61 prostate cancer PCa 61 kinase inhibition 61 sitaxsentan 61 DAVANAT 61 afamelanotide 61 ® lenalidomide 61 antiviral potency 61 abciximab 61 thromboxane A2 61 colorectal adenoma 61 antiangiogenic 61 CYT# QbG# 61 trastuzumab Herceptin R 61 long acting muscarinic 61 CHARISMA trial 61 #I TM# 61 highly immunogenic 61 CorVue ™ 61 Akt inhibitor 61 antimitotic 61 antiangiogenic agents 61 IFN α 61 non nucleoside 61 Anticalins R 61 mertansine 61 volociximab 61 glatiramer acetate Copaxone 61 CYP#A# inhibitors 61 pomalidomide 61 beta lactam antibiotic 61 antithrombotic 61 transgenic mouse models 61 Combination therapy 61 liposome formulation 61 antitumour 61 clinically meaningful improvement 61 symptomatic VTE 61 RhuDex ® 61 Irinotecan 61 CEACAM1 61 HQK 61 protein tyrosine phosphatase 61 PSN# [001] 61 INT# [002] 61 anti CD3 61 ancrod 61 Dabigatran etexilate 61 lactate dehydrogenase LDH 61 protease inhibitor PI 61 potently inhibited 61 plasma kallikrein 61 xanthine oxidase inhibitor 61 reslizumab 61 subcutaneous SC 61 HepDirect prodrug 61 BMS# 61 brivaracetam 61 osteoblast 61 Triapine R 61 Ambrisentan 61 eplerenone 61 CRF antagonists 61 DermaVir Patch 61 EGFR HER2 61 favorable pharmacokinetic 61 noninferior 61 Interferon beta 61 ELACYT 61 Angiolix 61 Darinaparsin 61 potent inhibitor 61 safety tolerability pharmacokinetic 61 SIR Spheres 61 microtubule targeting 61 evaluating tivozanib 61 potency selectivity 61 multicenter randomized placebo controlled 61 Oral NKTR 61 gene amplification 61 beta adrenergic 61 intra arterial 61 Arranon 61 immunohistochemical 61 Galectin 3 61 2 methoxyestradiol #ME# 61 BMS # 61 guanfacine 61 mineralocorticoid 61 conventional DMARDs 61 antiapoptotic 61 deferoxamine 61 airway responsiveness 61 HuMax CD# 61 proteasome inhibitor 61 torezolid 61 parathyroid hormone PTH 61 anti resorptive 61 atorvastatin #mg 61 azilsartan medoxomil 61 2A receptor agonist 61 triphendiol 61 ug dose 61 Tumor Response 61 LHRH agonists 61 tolerability pharmacokinetics 61 Granulocyte Colony Stimulating Factor 61 Cinacalcet HCl 61 agonism 61 fluvastatin 61 Pharmacokinetic analyzes 61 intradermal injections 61 davunetide intranasal AL 61 Akt activation 61 active comparator 61 cobiprostone 61 fulvestrant 61 Dacogen decitabine 61 KAPIDEX 61 NB S# strontium malonate 61 elotuzumab 61 chondroitin sulphate 61 incyclinide 61 alkaline phosphatase ALP 61 ARB telmisartan 61 cisplatin gemcitabine 61 Plasmin 61 NP2 Enkephalin 61 Bortezomib 61 Durezol 61 Belerofon 61 TNF Tumor Necrosis Factor 61 Pgp 61 visilizumab 61 Surgical resection 61 intensive lipid lowering 61 lanthanum carbonate 61 desvenlafaxine succinate 61 chimeric monoclonal antibody 61 urocortin 2 61 KB# [002] 61 denileukin diftitox 61 PI3K inhibitor 61 mesylate 61 histamine dihydrochloride 61 APOPTONE 61 tipifarnib 61 subconjunctival injection 61 pitavastatin 61 FK# 61 huN# DM1 61 nanomolar 61 radiation dosimetry 61 Phase Ib clinical 61 ULORIC 61 Pyridorin 61 small molecule tyrosine 61 novel prodrug 61 T1 weighted images 61 artery stenosis 61 antitumoral 61 erlotinib Tarceva ® 61 HSP# inhibitor 61 5alpha reductase 61 romidepsin 61 immunohistochemical analysis 61 nab paclitaxel 61 lumiliximab 61 oral anticoagulation 61 antidepressant efficacy 61 intratumoral 61 dose atorvastatin 61 phase Ib 61 morphometric vertebral fractures 61 QTc prolongation 61 lymphocyte counts 61 BrachySil ™ 61 XmAb# 61 Lenalidomide 61 GnRH antagonist 61 gemcitabine carboplatin 61 angiographically 61 monoclonal anti 61 #HT#A 61 Certolizumab pegol 61 ADAMTS# 61 HuLuc# 61 LCP Tacro TM 61 5 HT4 receptor 61 TRAIL induced apoptosis 61 mesalazine 61 bactericidal activity 61 peptide CGRP 61 CRLX# 61 metastatic malignant 61 hyperphenylalaninemia HPA due 61 Poly ICLC 61 PlGF 61 stavudine d4T 61 latanoprost 61 hapten 61 ABVD 61 Cytoxan 61 Insulin detemir 61 renal toxicity 61 Bezielle 61 GLPG# 61 transarterial 61 hMG 60 SERMs 60 oral antiviral 60 Protelos R 60 NexACT ® 60 lung fibrosis 60 febuxostat 60 inotropic 60 ACTOS ® 60 Deforolimus 60 ASTEROID 60 Apoptone 60 JAK2 inhibitors 60 generation purine nucleoside 60 amprenavir 60 inhibitory effect 60 ACTEMRA TM 60 reteplase 60 PHX# 60 PPARγ 60 PKC# 60 verteporfin 60 proton pump inhibitor PPI 60 adenosine A2A 60 #beta estradiol 60 everolimus eluting stents 60 orally administered inhibitor 60 topical diclofenac 60 Tolvaptan 60 reuptake inhibitor 60 murine models 60 lysophosphatidic acid 60 canakinumab 60 Marqibo TM 60 AChE inhibitors 60 darunavir r 60 immunomodulator 60 #mg QD [002] 60 ImmunoVEX HSV2 60 AIR# [001] 60 LAS# [002] 60 P selectin 60 canagliflozin 60 HGS# 60 EGFR TKI 60 HIF 1α 60 membranous nephropathy 60 enkephalin 60 Ophena 60 Pharmacodynamics 60 LCP AtorFen 60 INCB# [003] 60 CIMZIA R 60 Octreolin 60 midstage clinical 60 D aspartate NMDA receptor 60 zileuton 60 menadione 60 Posiphen 60 pyridostigmine 60 RH1 60 Tesmilifene 60 talabostat 60 siRNA knockdown 60 muscarinic antagonist 60 intravenous cyclophosphamide 60 PDE4 inhibitors 60 tenecteplase 60 anthracycline chemotherapy 60 fondaparinux 60 rFSH 60 AZT zidovudine Retrovir 60 ACZ# 60 cefuroxime 60 Fc fusion protein 60 phenelzine 60 Xelox 60 ATL# [001] 60 ganetespib 60 reversible inhibitor 60 neointimal hyperplasia 60 nebulization 60 erlotinib Tarceva 60 LSI #P 60 MoxDuo 60 intact parathyroid hormone 60 GSK# [001] 60 Bendavia 60 KRN# 60 rBChE 60 antitumor effects 60 unconjugated 60 trans retinoic acid 60 FOLFOX6 60 imatinib resistance 60 PREZISTA r 60 allergic airway inflammation 60 recombinant interferon 60 muscarinic receptor 60 immunomodulating 60 pro angiogenic 60 cidofovir 60 transdermal estradiol 60 macrolide antibiotic 60 Imprime PGG 60 Gleevec resistant 60 GPIIb IIIa 60 factor G CSF 60 Lubiprostone 60 hepatotoxic 60 metabolically inert 60 metaplasia 60 vorinostat 60 vitro cytotoxicity 60 CIMZIA TM certolizumab pegol 60 Vaprisol 60 docetaxel Taxotere ® 60 AOD# [002] 60 doxorubicin docetaxel 60 SGLT2 inhibitors 60 xenograft model 60 PSN# [002] 60 isoproterenol 60 tamoxifen Nolvadex ® 60 vasodilatory 60 carcinoembryonic antigen 60 PegIFN 60 Olmesartan 60 IGFBP 3 60 rtPA 60 estramustine 60 BRAF inhibitors 60 optimal dosing 60 IOP lowering 60 somatostatin analogues 60 perfusion MRI 60 selective A2A adenosine receptor 60 refractory CLL 60 catheter occlusion 60 RhuDex TM 60 eprotirome 60 maximal dose 60 flutamide 60 adriamycin 60 NOX E# 60 donepezil Aricept 60 flecainide 60 nucleoside reverse transcriptase inhibitor 60 cediranib 60 Amrubicin 60 epoetin alpha 60 LHRH receptor positive 60 tacrolimus ointment 60 antiangiogenic activity 60 pioglitazone HCl 60 potent cytotoxic 60 ACEIs 60 Factor Xa inhibitor 60 tinzaparin 60 lomitapide 60 deferasirox 60 calcitonin 60 LHRH antagonists 60 phase IIa clinical 60 omega interferon 60 adjuvant cisplatin 60 apolipoproteins 60 mu opioid receptor antagonist 60 RRMS patients 60 chemoresistant 60 Perforomist ™ Inhalation Solution 60 Valdoxan 60 IMiDs ® 60 selegiline 60 chlamydial 60 potent suppressor 60 CYP#D# inhibitor 60 Multiple Ascending Dose 60 orthotopic 60 oral talactoferrin 60 symptomatic paroxysmal AF 60 NV1FGF 60 orBec 60 oral Xeloda 60 Alequel 60 atacicept 60 5 HT2A 60 serotonin norepinephrine reuptake inhibitor 60 Aeroquin 60 ORMD 60 dexpramipexole 60 limiting toxicity DLT 60 Dapagliflozin 60 certolizumab 60 endothelin receptor antagonists 60 zoledronate 60 abluminal 60 RSD# 60 malignant ascites 60 PD LID 60 acromegalic patients 60 ONCONASE R 60 OvaRex R 60 GOUT 60 antitumor efficacy 60 angiotensin receptor blocker ARB 60 MIRCERA 60 convenient dosing regimens 60 vWF 60 idarubicin 60 NeuroSTAT ® 60 anti angiogenic agents 60 Cloretazine 60 placebo controlled clinical 60 db db mice 60 mitoxantrone plus 60 Bendamustine 60 Tanespimycin 60 lapatinib Tykerb 60 TNF alpha inhibitor 60 interferon ribavirin 60 HuMax CD4 60 thermosensitive 60 PrevOnco ™ 60 DLTs 60 STRIDE PD 60 continuous intravenous infusion 60 iroxanadine 60 acadesine 60 varespladib 60 liver histology 60 inosine 60 #beta HSD1 60 otamixaban 60 GP IIb IIIa inhibitors 60 PI3K/mTOR 60 HDACi 60 sulodexide 60 darunavir ritonavir 60 oral picoplatin 60 relapsed ovarian cancer 60 Histalean TM 60 intravenous immunoglobulin IVIg 60 chemotherapy docetaxel 60 Subgroup analyzes 60 efficacy tolerability 60 Maximum Tolerated Dose MTD 60 synthetic siRNA 60 Enhanze Technology 60 inhaled iloprost 60 stratifying patients 60 ß blockers 60 Parathyroid hormone 60 OncoGel 60 Alkaline Phosphatase 60 Eltrombopag 60 6R BH4 60 PEGylated Fab fragment 60 lenalidomide Revlimid R 60 enzyme inhibitor 60 Lisofylline LSF 60 IntroductionThe 60 pharmacologically active 60 Cytochrome P# 60 gp# protein [002] 60 ACAPODENE TM 60 icatibant 60 Pharmacodynamic 60 rFIXFc 60 IgG1 antibodies 60 glutamyl 60 cariprazine 60 rNAPc2 60 sulphonylureas 60 immunosuppressive regimen 60 #ME# 60 PEGylated interferon beta 1a 60 eluting stent 60 5 HT6 receptor 60 natriuretic peptide 60 cinacalcet 60 Randomized controlled 60 Sym# 60 mycophenolate mofetil 60 Lodamin 60 PS# [001] 60 dopamine D2 60 tocilizumab 60 aurora kinase 60 dasatinib Sprycel 60 rifalazil 60 mineralocorticoid receptor